Alvotech (ALVO) Invested Capital (2020 - 2026)
Alvotech's (ALVO) quarterly Invested Capital came in at $42.5 million in Q1 2026, up 29.81% YoY from $32.8 million in Q1 2025, and down 98.05% on a QoQ basis from $2.2 billion in Q4 2025.
Alvotech (ALVO) Invested Capital (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has 7 years of Invested Capital data on file, last reported at $42.5 million in Q1 2026.
- Quarterly Invested Capital rose 29.81% year-over-year to $42.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 billion (up 8.46% YoY) and the FY2025 annual result came in at $2.2 billion, up 8.53% from the prior year.
- Invested Capital retreated to $42.5 million in Q1 2026, from $2.2 billion in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $2.2 billion in Q4 2025 to a low of $22.2 million in Q3 2024.
- A 5-year average of $658.6 million and a median of $442.7 million in 2022 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2023 — Invested Capital jumped 569.2% — and 2025, when it slipped 12.78%.
- Tracing ALVO's Invested Capital over 5 years: stood at $764.6 million in 2022, then advanced by 25.58% to $960.2 million in 2023, then surged by 109.3% to $2.0 billion in 2024, then gained by 8.53% to $2.2 billion in 2025, then tumbled by 98.05% to $42.5 million in 2026.
- The last three Invested Capital figures came in at $42.5 million (Q1 2026), $2.2 billion (Q4 2025), and $42.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | 630.00 Mn |
| 10 | Alvotech | 1.24 Bn | 1.24 Bn | 5.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.51 Mn |
| Dec 31, 2025 | 2.18 Bn |
| Sep 30, 2025 | 42.72 Mn |
| Jun 30, 2025 | 1.12 Bn |
| Mar 31, 2025 | 32.75 Mn |
| Dec 31, 2024 | 2.01 Bn |
| Sep 30, 2024 | 22.22 Mn |
| Jun 30, 2024 | 1.06 Bn |
| Mar 31, 2024 | 37.55 Mn |
| Dec 31, 2023 | 960.16 Mn |
| Jun 30, 2023 | 808.64 Mn |
| Mar 31, 2023 | 23.05 Mn |
| Dec 31, 2022 | 764.57 Mn |
| Jun 30, 2022 | 120.84 Mn |
| Dec 31, 2021 | 400.91 Mn |
| Dec 31, 2020 | 567.90 Mn |